Let-7 microrna and mimetics thereof as therapeutics for cancer
Patent Information
- Authority / Receiving Office
- US · United States
- Current Assignee / Owner
- IMMUNE DISEASE INST INC
- Publication Date
- 2010-12-09
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
CROSS REFERENCED APPLICATIONS
[0001] This Application claims benefit under 35 U.S.C. §119(e) of U.S. Provisional Application Ser. No. 60 / 898,610 filed Jan. 31, 2007, the contents of which is incorporated herein in its entirety by reference.GOVERNMENT SUPPORT
[0002] This invention was made with government support to ES under Contract No. 30525022 awarded by the National Science Foundation of China, Contract No. 2005CB724605 awarded by the 973 Program Project from Ministry of Science and Technology of China.BACKGROUND OF THE INVENTION
[0003] Accumulating evidence suggests that many cancers are maintained in a hierarchical organization of rare, slowly dividing tumor-initiating cells, rapidly dividing amplifying cells (precursor cells) and differentiated tumor cells1,2. Tumor-initiating (also termed cancer stem) cells have been identified in hematologic3-5, brain6-8, breast9,10 prostate11 and colon cancers12. Stem cells, which are self-renewing and can differentiate into heterogeneous cell po...